JNJ

225.03

-1.07%↓

UNH

367.11

-0.51%↓

TMO

467.19

-0.45%↓

ISRG

459.85

+0.49%↑

ABT

89.2

-0.35%↓

JNJ

225.03

-1.07%↓

UNH

367.11

-0.51%↓

TMO

467.19

-0.45%↓

ISRG

459.85

+0.49%↑

ABT

89.2

-0.35%↓

JNJ

225.03

-1.07%↓

UNH

367.11

-0.51%↓

TMO

467.19

-0.45%↓

ISRG

459.85

+0.49%↑

ABT

89.2

-0.35%↓

JNJ

225.03

-1.07%↓

UNH

367.11

-0.51%↓

TMO

467.19

-0.45%↓

ISRG

459.85

+0.49%↑

ABT

89.2

-0.35%↓

JNJ

225.03

-1.07%↓

UNH

367.11

-0.51%↓

TMO

467.19

-0.45%↓

ISRG

459.85

+0.49%↑

ABT

89.2

-0.35%↓

Search

Odonate Therapeutics Inc

Fermé

0

Résumé

Variation du prix de l'action

24h

Actuel

Min

Max

Chiffres clés

By Trading Economics

Odonate Therapeutics Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

3 mai 2026, 23:47 UTC

Résultats

National Australia Bank Warns of Economic Shock as 1st Half Profit Falls -- Update

3 mai 2026, 22:35 UTC

Résultats

National Australia Bank Holds Dividend Despite 19% 1st Half Profit Drop

3 mai 2026, 23:39 UTC

Market Talk

Gold Edge Higher Amid Signs of Resilience -- Market Talk

3 mai 2026, 23:34 UTC

Market Talk

Oil Declines Amid Mild Risk-on Sentiment -- Market Talk

3 mai 2026, 23:32 UTC

Résultats

National Australia Bank Warns of Economic Shock as 1H Profit Falls -- Update

3 mai 2026, 23:30 UTC

Market Talk

Nickel Industries Result Shows Power of Higher Prices -- Market Talk

3 mai 2026, 23:20 UTC

Market Talk

RBA Likely to Hike Rates; Guidance and Board Split Key -- Market Talk

3 mai 2026, 23:16 UTC

Acquisitions, Fusions, Rachats

GameStop Is Offering to Buy eBay for $56 Billion, CEO Ryan Cohen Says -- WSJ

3 mai 2026, 22:57 UTC

Acquisitions, Fusions, Rachats

GameStop Is Offering to Buy eBay For $56 Billion, CEO Ryan Cohen Says -- WSJ

3 mai 2026, 22:57 UTC

Acquisitions, Fusions, Rachats

GameStop Has Roughly 5% Stake in eBay, Cohen Says -- WSJ

3 mai 2026, 22:57 UTC

Acquisitions, Fusions, Rachats

GameStop Offering to Buy eBay for $125 a Share, or About $56 Billion, CEO Ryan Cohen Says -- WSJ

3 mai 2026, 22:57 UTC

Acquisitions, Fusions, Rachats

GameStop Is Prepared to Run Proxy Fight If eBay Isn't Receptive to a Deal, Cohen Says -- WSJ

3 mai 2026, 22:57 UTC

Acquisitions, Fusions, Rachats

GameStop Has Around $20 Billion in Debt Financing Committed From TD Bank, Cohen Says -- WSJ

3 mai 2026, 22:45 UTC

Market Talk

Global Equities Roundup: Market Talk

3 mai 2026, 22:45 UTC

Market Talk

Low-Cost Miners in Spotlight Amid High Energy Prices -- Market Talk

3 mai 2026, 22:20 UTC

Résultats

National Australia Bank Holds Dividend Despite 19% 1H Profit Drop

3 mai 2026, 22:08 UTC

Résultats

NAB's 1H Included Previously Announced A$1.35B Software Amortization Charge>NAB.AU

3 mai 2026, 22:05 UTC

Résultats

NAB 1H Net Interest Income A$9.16B Vs. A$8.445B>NAB.AU

3 mai 2026, 22:05 UTC

Résultats

NAB 1H Credit Impairment Charge A$706M Vs. A$348M>NAB.AU

3 mai 2026, 22:05 UTC

Résultats

NAB 1H Operating Expenses A$5.02B Vs. A$4.81B>NAB.AU

3 mai 2026, 22:04 UTC

Résultats

NAB 1H Net Interest Margin 1.81%>NAB.AU>NAB.AU

3 mai 2026, 22:03 UTC

Résultats

NAB 1H Cash Return on Equity Ex-Large Notable Items 11.6%>NAB.AU

3 mai 2026, 22:03 UTC

Résultats

NAB 1H Cash Return on Equity 8.5%>NAB.AU

3 mai 2026, 22:02 UTC

Résultats

NAB 1H CET1 Capital Ratio 11.65% Vs. 12.01%>NAB.AU

3 mai 2026, 22:02 UTC

Résultats

NAB 1H Cash Earnings A$2.64B>NAB.AU

3 mai 2026, 22:02 UTC

Résultats

NAB 1H Cash Earnings Ex-Notable Items A$3.59B Vs. A$3.58B>NAB.AU

3 mai 2026, 22:01 UTC

Résultats

National Australia Bank Keeps Dividend at A$0.85 >NAB.AU

3 mai 2026, 22:01 UTC

Résultats

National Australia Bank 1H Rev A$11.16B Vs. A$10.28B >NAB.AU

3 mai 2026, 22:01 UTC

Résultats

National Australia Bank 1H Net A$2.75B Vs. Net A$3.41B >NAB.AU

3 mai 2026, 15:06 UTC

Résultats

Berkshire's Greg Abel Marks His First Annual Meeting as CEO. We'd Give Him a B-Plus. -- Barrons.com

Comparaison

Variation de prix

Odonate Therapeutics Inc prévision

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

EBITDA

Bénéfice d'exploitation

$

À Propos Odonate Therapeutics Inc

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.
help-icon Live chat